Edition:
United Kingdom

Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

95.04USD
13 Nov 2018
Change (% chg)

$-1.03 (-1.07%)
Prev Close
$96.07
Open
$96.25
Day's High
$96.35
Day's Low
$94.34
Volume
204,614
Avg. Vol
268,152
52-wk High
$116.43
52-wk Low
$90.31

Latest Key Developments (Source: Significant Developments)

Quest Diagnostics Reports Q3 Reported Diluted EPS Of $1.53
Tuesday, 23 Oct 2018 

Oct 23 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.THIRD QUARTER REVENUES OF $1.89 BILLION, UP 1.8% FROM 2017.UPDATES OUTLOOK FOR FULL-YEAR 2018.THIRD QUARTER REPORTED DILUTED EPS OF $1.53.SEES FY 18 REPORTED DILUTED EPS NOW EXPECTED TO BE BETWEEN $5.57 AND $5.64.THIRD QUARTER ADJUSTED DILUTED EPS EXCLUDING AMORTIZATION OF $1.68.SEES FY 2018 REPORTED REVENUES NOW EXPECTED TO BE APPROXIMATELY $7.62 BILLION.SEES FY 18 ADJUSTED DILUTED EPS EXCLUDING AMORTIZATION EXPENSE NOW EXPECTED TO BE BETWEEN $6.53 AND $6.60.  Full Article

Oxford Immunotec Sells U.S. Lab Services Business For $170 Mln To Quest Diagnostics - SEC Filing
Tuesday, 25 Sep 2018 

Sept 25 (Reuters) - Quest Diagnostics Inc ::OXFORD IMMUNOTEC GLOBAL PLC - TO SELL ITS U.S. LABORATORY SERVICES BUSINESS FOR GROSS PROCEEDS OF $170 MILLION IN CASH TO QUEST DIAGNOSTICS - SEC FILING.OXFORD IMMUNOTEC GLOBAL PLC - WILL UPDATE FULL YEAR 2018 REVENUE GUIDANCE UPON CLOSING OF TRANSACTION.  Full Article

Quest To Acquire U.S. Laboratory Services Business Of Oxford Immunotec
Tuesday, 25 Sep 2018 

Sept 25 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS TO ACQUIRE U.S. LABORATORY SERVICES BUSINESS OF OXFORD IMMUNOTEC.QUEST DIAGNOSTICS INC - PARTIES EXPECT TO ENTER INTO A STRATEGIC COLLABORATION AGREEMENT TO DRIVE CONTINUED GROWTH OF T-SPOT.TB TESTING IN U.S.QUEST DIAGNOSTICS INC - INTENDS TO CONTINUE TO OFFER QUANTIFERON TB BLOOD TESTING SERVICES TO PROVIDE PHYSICIANS CHOICE IN BLOOD-BASED TB TESTING.QUEST DIAGNOSTICS - OXFORD IMMUNOTEC TO SELL T-SPOT.TB TEST KITS & RELATED ACCESSORIES TO CO UNDER TERMS OF A LONG-TERM SUPPLY AGREEMENT.  Full Article

Quest Diagnostics Acquires Reprosource
Monday, 24 Sep 2018 

Sept 24 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS ACQUIRES REPROSOURCE, EXTENDING INTO ADVANCED FERTILITY DIAGNOSTICS.QUEST DIAGNOSTICS INC - ADDITIONAL TERMS WERE NOT DISCLOSED..  Full Article

Provant Health Enters Into Asset Purchase Agreement With Summit Health
Monday, 27 Aug 2018 

Aug 27 (Reuters) - Quest Diagnostics Inc ::PROVANT HEALTH ENTERS INTO ASSET PURCHASE AGREEMENT WITH SUMMIT HEALTH, UNIT OF QUEST DIAGNOSTICS.HOOPER HOLMES - QUEST ASSET PURCHASE AGREEMENT IS VALUED AT $27 MILLION, TAKES FORM OF A "STALKING HORSE" BID.HOOPER HOLMES - IN CONJUNCTION WITH SALE PROCESS, CO PETITIONED FOR CHAPTER 11 BANKRUPTCY ON MONDAY, AUG. 27.HOOPER HOLMES - QUEST ASSET PURCHASE DEAL CONTAINS TRANSITION SERVICES AGREEMENT THROUGH DEC. 31.  Full Article

UnitedHealthcare Establishes Partnership With Quest Diagnostics
Thursday, 24 May 2018 

May 24 (Reuters) - Quest Diagnostics Inc ::UNITEDHEALTHCARE ESTABLISHES LONG-TERM STRATEGIC PARTNERSHIP WITH QUEST DIAGNOSTICS.QUEST DIAGNOSTICS INC - CO, UNITEDHEALTHCARE HAVE ESTABLISHED A LONG-TERM STRATEGIC PARTNERSHIP.  Full Article

Quest Diagnostics provides update on impact of 2018 Medicare payment rates
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Quest Diagnostics Inc ::Quest Diagnostics provides update on impact of final 2018 Medicare payment rates for clinical laboratory tests.Quest Diagnostics Inc - ‍expects impact of final fee schedule rates under Protecting Access To Medicare Act​ (PAMA) to be about 4% in 2018.Quest Diagnostics Inc - ‍expects impact of final fee schedule rates under PAMA to be about 10% in 2019 and 2020.  Full Article

FDA approves Clinical Genomics, Quest Diagnostics Insure One
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Quest Diagnostics Inc :Clinical Genomics and Quest Diagnostics announce FDA 510(k) clearance of Insure® One™.Quest Diagnostics Inc- ‍insure One is expected to be commercially available in early 2018​.  Full Article

Quest Diagnostics acquires certain assets of California Laboratory Associates
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Quest Diagnostics Inc :Quest Diagnostics acquires California Laboratory Associates.Quest Diagnostics Inc - ‍financial terms of agreement were not disclosed.​.Quest Diagnostics Inc - ‍it has acquired certain assets of California Laboratory Associates, a clinical lab network​.  Full Article

Advantage Capital Portfolio company Cleveland Heartlab acquired by Quest Diagnostics
Thursday, 19 Oct 2017 

Oct 19 (Reuters) - Quest Diagnostics Inc :Advantage Capital Portfolio company Cleveland Heartlab, Inc acquired by Quest Diagnostics.‍cleveland Heartlab says Quest to maintain Cleveland Heartlab's clinic location in Cleveland's midtown area.  Full Article

RPT-EXPLAINER-Why it’s so hard to diagnose Zika

CHICAGO, Oct 17 When a Zika epidemic was at its height in the Americas two years ago, diagnostics makers began working feverishly to create diagnostic tests for a virus that few in the U.S. had heard of.